We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+9.44%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$693M
AUM Growth
+$45.3M
(+7%)
Cap. Flow
-$3.57M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
27.41%
Holding
501
New
6
Increased
–
Reduced
6
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$2M |
| 2 |
PPLI
People Inc
PPLI
|
+$216K |
| 3 |
VMW
VMware, Inc
VMW
|
+$207K |
| 4 |
Cogent Communications
CCOI
|
+$196K |
| 5 |
Viasat
VSAT
|
+$194K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$1.61M |
| 2 |
APEN
Apollo Endosurgery, Inc.
APEN
|
+$1.29M |
| 3 |
MGI
MoneyGram International, Inc. New
MGI
|
+$1.04M |
| 4 |
TA
TravelCenters of America LLC
TA
|
+$865K |
| 5 |
HSKA
Heska Corp
HSKA
|
+$683K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.14% |
| 2 | Healthcare | 14.27% |
| 3 | Industrials | 11.75% |
| 4 | Financials | 10.7% |
| 5 | Consumer Discretionary | 8.62% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q2 2023 Portfolio in Review
As of Q2 2023, NJ State Employees Deferred Compensation Plan held 501 positions worth $693M, up 7% from $648M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4%. NJ State Employees Deferred Compensation Plan opened 6 new positions and exited 14, leaving the 501-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- NJ State Employees Deferred Compensation Plan's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 19,000 shares worth $1.95M.
- NJ State Employees Deferred Compensation Plan's biggest Q2 2023 reduction was Concentrix, cutting an estimated $88.6K.
- NJ State Employees Deferred Compensation Plan fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.61M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 27% of its $693M portfolio in Q2 2023.
- NJ State Employees Deferred Compensation Plan opened 6 new positions and closed 14 in Q2 2023.
- NJ State Employees Deferred Compensation Plan's portfolio value rose 7% quarter-over-quarter to $693M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2023, filed 2 Aug 2023.